ArticleNeuro-oncology advances

Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature.

Yen-Ting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.